CA Patent

CA2020073A1 — Substituted quinazolinones as angiotensin ii antagonists

Assigned to Merck and Co Inc · Expires 1991-01-04 · 35y expired

What this patent protects

TITLE OF THE INVENTION SUBSTITUTED QUINAZOLINONES AS ANGIOTENSIN II ANTAGONISTS ABSTRACT OF THE INVENTION Novel substituted quinazolinones of the formula (I), which are useful as angiotensin II antagonists, are disclosed. (I)

USPTO Abstract

TITLE OF THE INVENTION SUBSTITUTED QUINAZOLINONES AS ANGIOTENSIN II ANTAGONISTS ABSTRACT OF THE INVENTION Novel substituted quinazolinones of the formula (I), which are useful as angiotensin II antagonists, are disclosed. (I)

Drugs covered by this patent

Patent Metadata

Patent number
CA2020073A1
Jurisdiction
CA
Classification
—
Expires
1991-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.